Literature DB >> 26901579

Rhizosecretion improves the production of Cyanovirin-N in Nicotiana tabacum through simplified downstream processing.

Julian K-C Ma1, Pascal M W Drake1, Luisa M Madeira1, Tim H Szeto1.   

Abstract

Rhizosecretion has many advantages for the production of recombinant pharmaceuticals, notably facile downstream processing from hydroponic medium. The aim of this study was to increase yields of the HIV microbicide candidate, Cyanovirin-N (CV-N), obtained using this production platform and to develop a simplified methodology for its downstream processing from hydroponic medium. Placing hydroponic cultures on an orbital shaker more than doubled the concentration of CV-N in the hydroponic medium compared to plants which remained stationary, reaching a maximum of approximately 20μg/ml in one week, which is more than 3 times higher than previously reported yields. The protein composition of the hydroponic medium, the rhizosecretome, was characterised in plants cultured with or without the plant growth regulator alpha-napthaleneacetic acid by LC-ESI-MS/MS, and CV-N was the most abundant protein. The issue of large volumes in the rhizosecretion system was addressed by using ion exchange chromatography to concentrate CV-N and partially remove impurities. The semi-purified CV-N was demonstrated to bind to HIV gp120 in an ELISA and to neutralise HIVBa-L with an IC50 of 6nM in a cell-based assay. Rhizosecretion is therefore a practicable and inexpensive method for the production of functional CV-N.
Copyright © 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Cyanovirin-N; HIV microbicide; Hydroponic medium; Molecular pharming; Rhizosecretion

Mesh:

Substances:

Year:  2016        PMID: 26901579      PMCID: PMC4929045          DOI: 10.1002/biot.201500371

Source DB:  PubMed          Journal:  Biotechnol J        ISSN: 1860-6768            Impact factor:   4.677


  30 in total

Review 1.  Microbicides and other topical strategies to prevent vaginal transmission of HIV.

Authors:  Michael M Lederman; Robin E Offord; Oliver Hartley
Journal:  Nat Rev Immunol       Date:  2006-05       Impact factor: 53.106

2.  Hydrophobin (HFBI): A potential fusion partner for one-step purification of recombinant proteins from insect cells.

Authors:  Tomi Lahtinen; Markus B Linder; Tiina Nakari-Setälä; Christian Oker-Blom
Journal:  Protein Expr Purif       Date:  2008-01-11       Impact factor: 1.650

3.  High-yield production of a human monoclonal IgG by rhizosecretion in hydroponic tobacco cultures.

Authors:  Luisa M Madeira; Tim H Szeto; Maurice Henquet; Nicole Raven; John Runions; Jon Huddleston; Ian Garrard; Pascal M W Drake; Julian K-C Ma
Journal:  Plant Biotechnol J       Date:  2015-06-03       Impact factor: 9.803

4.  Protease activity of CND41, a chloroplast nucleoid DNA-binding protein, isolated from cultured tobacco cells.

Authors:  S Murakami; Y Kondo; T Nakano; F Sato
Journal:  FEBS Lett       Date:  2000-02-18       Impact factor: 4.124

5.  Tissue specificity of tobacco peroxidase isozymes and their induction by wounding and tobacco mosaic virus infection.

Authors:  L M Lagrimini; S Rothstein
Journal:  Plant Physiol       Date:  1987-06       Impact factor: 8.340

6.  Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.

Authors:  Myriam Witvrouw; Valery Fikkert; Anke Hantson; Christophe Pannecouque; Barry R O'keefe; James McMahon; Leonidas Stamatatos; Erik de Clercq; Anders Bolmstedt
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Cyanovirin-N potently inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models.

Authors:  Viviana Buffa; Daniel Stieh; Naheed Mamhood; Qinxue Hu; Patricia Fletcher; Robin J Shattock
Journal:  J Gen Virol       Date:  2009-01       Impact factor: 3.891

8.  Functional homologs of cyanovirin-N amenable to mass production in prokaryotic and eukaryotic hosts.

Authors:  Toshiyuki Mori; Laura G Barrientos; Zhaozhong Han; Angela M Gronenborn; Jim A Turpin; Michael R Boyd
Journal:  Protein Expr Purif       Date:  2002-10       Impact factor: 1.650

9.  Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays.

Authors:  David C Montefiori
Journal:  Curr Protoc Immunol       Date:  2005-01

10.  Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques.

Authors:  Che-Chung Tsai; Peter Emau; Yonghou Jiang; Baoping Tian; William R Morton; Kirk R Gustafson; Michael R Boyd
Journal:  AIDS Res Hum Retroviruses       Date:  2003-07       Impact factor: 2.205

View more
  6 in total

1.  Strategies for Efficient and Sustainable Protein Extraction and Purification from Plant Tissues.

Authors:  Johannes F Buyel
Journal:  Methods Mol Biol       Date:  2022

Review 2.  An update of the recombinant protein expression systems of Cyanovirin-N and challenges of preclinical development.

Authors:  Hajie Lotfi; Roghayeh Sheervalilou; Nosratollah Zarghami
Journal:  Bioimpacts       Date:  2017-11-16

Review 3.  Plant Molecular Farming - Integration and Exploitation of Side Streams to Achieve Sustainable Biomanufacturing.

Authors:  Johannes F Buyel
Journal:  Front Plant Sci       Date:  2019-01-18       Impact factor: 5.753

4.  Engineering the interactions between a plant-produced HIV antibody and human Fc receptors.

Authors:  Szymon Stelter; Mathew J Paul; Audrey Y-H Teh; Melanie Grandits; Friedrich Altmann; Jessica Vanier; Muriel Bardor; Alexandra Castilho; Rachel Louise Allen; Julian K-C Ma
Journal:  Plant Biotechnol J       Date:  2019-08-10       Impact factor: 9.803

Review 5.  Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes.

Authors:  Fernando Notario-Pérez; Roberto Ruiz-Caro; María-Dolores Veiga-Ochoa
Journal:  Drug Des Devel Ther       Date:  2017-06-15       Impact factor: 4.162

Review 6.  Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.

Authors:  Maria Lobato Gómez; Xin Huang; Derry Alvarez; Wenshu He; Can Baysal; Changfu Zhu; Victoria Armario-Najera; Amaya Blanco Perera; Pedro Cerda Bennasser; Andera Saba-Mayoral; Guillermo Sobrino-Mengual; Ashwin Vargheese; Rita Abranches; Isabel Alexandra Abreu; Shanmugaraj Balamurugan; Ralph Bock; Johannes F Buyel; Nicolau B da Cunha; Henry Daniell; Roland Faller; André Folgado; Iyappan Gowtham; Suvi T Häkkinen; Shashi Kumar; Sathish Kumar Ramalingam; Cristiano Lacorte; George P Lomonossoff; Ines M Luís; Julian K-C Ma; Karen A McDonald; Andre Murad; Somen Nandi; Barry O'Keefe; Kirsi-Marja Oksman-Caldentey; Subramanian Parthiban; Mathew J Paul; Daniel Ponndorf; Elibio Rech; Julio C M Rodrigues; Stephanie Ruf; Stefan Schillberg; Jennifer Schwestka; Priya S Shah; Rahul Singh; Eva Stoger; Richard M Twyman; Inchakalody P Varghese; Giovanni R Vianna; Gina Webster; Ruud H P Wilbers; Teresa Capell; Paul Christou
Journal:  Plant Biotechnol J       Date:  2021-07-19       Impact factor: 13.263

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.